Morosil® (Moro Red Orange Extract — Bionap)

Citrus sinensis (L.) Osbeck, Moro cultivar
Evidence Level
Limited
3 Clinical Trials
4 Documented Benefits
2/5 Evidence Score

Morosil is a standardized extract of juice from Moro blood oranges grown in Sicily, made by Bionap. It is rich in anthocyanins (mainly cyanidin 3-glucoside), along with hesperidin and vitamin C, and has been studied at 400 mg a day for body weight and body fat. A pooled analysis of three small randomized trials (252 adults in total) found about 2 kg more weight loss and 1.5 kg more fat loss than placebo, with no effect on lean mass, while waist results varied widely from trial to trial. The largest single trial lasted 6 months, was funded by the maker, and had everyone follow a calorie-controlled diet and exercise. One published case report describes acute liver failure needing a transplant in a woman who had started Morosil a month earlier; a single case cannot prove the extract caused it, but people with liver concerns should talk to a doctor first.

Studied Dose 400 mg a day of Morosil in the 12-week and 6-month placebo-controlled trials, taken as one capsule after breakfast in the 6-month trial alongside a calorie-controlled diet and exercise.
Active Compound Anthocyanins (cyanidin 3-glucoside dominant), hydroxycinnamic acids, flavone glycosides, ascorbic acid

Benefits

Body weight and fat mass loss alongside diet

Across three small randomized trials pooled in one analysis (252 adults), Moro orange extract was linked to about 2 kg more weight loss (95% CI 0.67 to 3.50 kg) and 1.5 kg more fat loss than placebo, with no effect on lean mass. The trials were small and the largest was maker-funded, so treat this as a possible add-on to diet and exercise, not a standalone fat burner.

Waist and hip circumference

In the 6-month trial, waist shrank 3.9 cm versus 1.7 cm on placebo and hip 3.4 cm versus 2.0 cm. The 12-week trial also reported waist and hip differences from placebo. When the trials were pooled, though, waist results disagreed almost completely between studies (I-squared 99%, p=0.05), so the waist effect is not settled.

Visceral and subcutaneous body fat

In the 6-month trial, body scans showed that visceral fat (around the organs) and subcutaneous fat (under the skin) fell more on the extract than on placebo (p=0.018 and p=0.006). This comes from one maker-funded trial in which everyone was also dieting, and the pooled analysis did not report visceral fat, so it has not been confirmed.

Anthocyanin antioxidant content

Moro is the most deeply pigmented blood orange variety, with juice averaging about 140 mg of anthocyanins per liter, mainly cyanidin 3-glucoside. The extract used in the 6-month trial contained 0.635% cyanidin 3-glucoside and 4.5% vitamin C. This describes what is in the product; the Morosil trials measured body size and composition, not antioxidant status.

Mechanism of action

1

Inhibits adipogenesis

In lab dishes, not in people, Morosil slowed the maturing of 3T3-L1 mouse fat-cell precursors into fat cells, lowering fat storage, the activity of fat-making genes and oxidative stress in the cells. Whether any of this happens in the human body is unknown.

2

PPAR-α activation and lipid homeostasis

In mice fed a high-fat diet for 12 weeks, Moro juice limited fat build-up in the liver by switching on PPAR-alpha and its target enzyme acyl-CoA oxidase, a key enzyme for burning fat, while switching off liver X receptor-alpha and the fat-making enzyme fatty acid synthase. This is an animal finding and has not been shown in people.

3

Anthocyanin-mediated metabolic modulation

Cyanidin 3-glucoside is thought to act on antioxidant, anti-inflammatory and metabolic pathways. In mice on a high-fat diet, Moro juice limited weight gain, improved insulin sensitivity and lowered triglycerides and total cholesterol. In the 6-month human trial, blood glucose, insulin and lipid measures did not change in either group.

Clinical trials

1
6-Month Morosil Trial in Overweight Adults
PubMed

Single-site, randomized, double-blind, placebo-controlled trial in Brisbane, Australia, of 400 mg a day of Morosil for 6 months alongside a calorie-controlled diet and exercise. Funded by Bionap, which also supplied the capsules (Briskey et al. 2022, Nutrients)

180 overweight but otherwise healthy adults aged 20 to 65 were randomized; 136 completed baseline and were analyzed (65 on Morosil, 71 on placebo) and 98 finished all 6 months.

After 6 months, body weight fell 4.2% versus 2.2% on placebo (p=0.015), with greater drops in BMI (p=0.019), waist (3.9 vs 1.7 cm), hip (3.4 vs 2.0 cm), fat mass (p=0.012) and visceral and subcutaneous fat. Weight differed significantly between groups at months 4 and 6. Liver markers stayed normal and glucose, insulin and lipids did not change. Two people on Morosil and five on placebo reported side effects such as nausea or constipation.

2
12-Week Morosil Trial in Overweight Adults
PubMed

Placebo-controlled trial of 400 mg a day of Morosil for 12 weeks in overweight healthy volunteers. The abstract does not give the number of participants or the funding source; the later 6-month trial report describes it as 60 adults (Cardile et al. 2015, Nat Prod Res)

Overweight healthy volunteers; 60 adults according to the later 6-month trial report.

BMI fell significantly after 4 weeks on Morosil, and at 12 weeks body weight, BMI, waist and hip circumference differed significantly from the placebo group (p<0.05). The abstract gives no effect sizes, and with about 60 people over 12 weeks the trial is too small to settle the question on its own.

3
Systematic Review and Meta-Analysis of Moro Orange Extract (2026)
PubMed

Systematic review and meta-analysis of randomized, placebo-controlled trials of Moro orange juice extract, searching PubMed, Embase and Cochrane (Campos et al. 2026, Nutr Health)

3 randomized trials with 252 overweight or obese adults in total.

Body weight fell 2.08 kg more than placebo (95% CI -3.50 to -0.67, I-squared 0%) and fat mass 1.53 kg more (95% CI -2.92 to -0.15, p=0.03). Waist results varied widely between trials (-3.25 cm, 95% CI -6.44 to -0.07, I-squared 99%, p=0.05). Lean mass did not change. BMI was a primary outcome, but the abstract gives no pooled BMI result. The authors call for more research on dose and duration.

Side effects and drug interactions

Common Potential side effects

Generally well tolerated in the trials so far, but the safety record is small: three randomized trials with 252 people in total, the longest lasting 6 months.
In the 6-month trial, liver markers (ALT, AST, GGT and bilirubin) stayed within the normal range at months 3 and 6 in both groups.
A published case report describes a 37-year-old woman who developed acute liver failure and needed a liver transplant after starting Morosil 30 days earlier. One case cannot show the extract caused it, but stop taking it and see a doctor promptly if you notice yellowing of the skin or eyes.
In the 6-month trial, 2 people on Morosil and 5 on placebo reported symptoms such as nausea, constipation or headache.
People allergic to oranges or other citrus fruit should avoid it.

Important Drug interactions

Theoretical only, with no cases reported in the published trials. Sweet orange is not grapefruit and its effect on the CYP3A4 drug-processing enzyme is different, but if you take a medicine that carries a grapefruit warning (some statins, calcium channel blockers, immunosuppressants), ask your prescriber first.
Theoretical caution with diabetes medicines: Moro juice improved insulin sensitivity in mice, although glucose and insulin did not change in the 6-month human trial.
Potential additive effects with weight-loss medications including GLP-1 agonists; not a clinically documented interaction but warrants monitoring.
No interactions with blood thinners have been reported, but the published trials were small and were not designed to detect drug interactions, so this is not evidence of safety.
If you have liver disease or take medicines that can strain the liver, ask your doctor before using it, given the published case of acute liver failure.

Frequently asked questions about Morosil® (Moro Red Orange Extract — Bionap)

What is Morosil?

Morosil is a standardized extract of juice from Moro blood oranges grown in Sicily, made by Bionap. It is rich in anthocyanins (mainly cyanidin 3-glucoside), along with hesperidin and vitamin C, and has been studied at 400 mg a day for body weight and body fat.

What is Morosil used for?

Morosil is researched primarily for Weight Management. Across three small randomized trials pooled in one analysis (252 adults), Moro orange extract was linked to about 2 kg more weight loss (95% CI 0.67 to 3.50 kg) and 1.5 kg more fat loss than placebo, with no effect on lean mass.

What is the recommended dosage of Morosil?

The clinically studied dose is 400 mg a day of Morosil in the 12-week and 6-month placebo-controlled trials, taken as one capsule after breakfast in the 6-month trial alongside a calorie-controlled diet and exercise. Always follow the product label and check with a healthcare provider for personal advice.

Is Morosil safe, and does it have side effects?

Side effects and cautions reported for Morosil include: Generally well tolerated in the trials so far, but the safety record is small: three randomized trials with 252 people in total, the longest lasting 6 months. It may also interact with some medications. Morosil is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Morosil interact with any medications?

Possible interactions include: Theoretical only, with no cases reported in the published trials. Sweet orange is not grapefruit and its effect on the CYP3A4 drug-processing enzyme is different, but if you take a medicine that carries a grapefruit warning (some statins, calcium channel blockers, immunosuppressa… If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Morosil?

NutraSmarts rates the evidence for Morosil as Limited (2 out of 5). It is backed by 3 study summaries and 6 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(6 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Campos CM, Gallo Ruelas M, Silva GHD, Lima FR, Holanda DF. Effect of Moro orange juice extract supplementation in weight management in adults: A systematic review and meta-analysis. Nutr Health. 2026;32(2):455-464. doi: 10.1177/02601060251374379.PubMedUsed to support: Meta-analysis of three randomized placebo-controlled trials (252 overweight or obese adults) of Moro orange juice extract: body weight -2.08 kg and fat mass -1.53 kg versus placebo, waist results highly inconsistent (I-squared 99%), no effect on lean mass.
  2. Briskey D, Malfa GA, Rao A. Effectiveness of "Moro" Blood Orange Citrus sinensis Osbeck (Rutaceae) Standardized Extract on Weight Loss in Overweight but Otherwise Healthy Men and Women-A Randomized Double-Blind Placebo-Controlled Study. Nutrients. 2022;14(3):427. doi: 10.3390/nu14030427.PubMedUsed to support: 6-month randomized, double-blind, placebo-controlled trial of 400 mg/day Morosil in 136 overweight adults on a calorie-controlled diet with exercise: weight -4.2% vs -2.2%, plus waist, hip, fat mass, visceral and subcutaneous fat differences; liver markers normal. Funded by Bionap (PMC full text).
  3. Cardile V, Graziano AC, Venditti A. Clinical evaluation of Moro (Citrus sinensis (L.) Osbeck) orange juice supplementation for the weight management. Nat Prod Res. 2015;29(23):2256-60. doi: 10.1080/14786419.2014.1000897.PubMedUsed to support: 12-week placebo-controlled trial of 400 mg/day Morosil in overweight healthy volunteers: BMI lower after 4 weeks; body weight, BMI, waist and hip differed from placebo at 12 weeks (p<0.05).
  4. Fernandes DP, De Ataide EC, Perales SR, Foratto A, Neto FC, Servian DCM, Boin IFSF. Acute Liver Failure Secondary to Anthocyanidin Use-A Case Report. Transplant Proc. 2023;55(6):1454-1456. doi: 10.1016/j.transproceed.2023.04.014.PubMedUsed to support: Case report: a 37-year-old woman developed acute liver failure requiring liver transplantation after starting Morosil 30 days earlier; the authors found no earlier reports of liver failure linked to Morosil.
  5. Salamone F, Li Volti G, Titta L, Puzzo L, Barbagallo I, La Delia F, Zelber-Sagi S, Malaguarnera M, Pelicci PG, Giorgio M, Galvano F. Moro orange juice prevents fatty liver in mice. World J Gastroenterol. 2012;18(29):3862-8. doi: 10.3748/wjg.v18.i29.3862.PubMedUsed to support: Mouse study: in mice on a high-fat diet, Moro juice limited weight gain, improved insulin sensitivity, lowered triglycerides and cholesterol, and reduced fatty liver via PPAR-alpha induction and liver X receptor-alpha suppression.
  6. Tomasello B, Malfa GA, La Mantia A, Miceli N, Sferrazzo G, Taviano MF, Di Giacomo C, Renis M, Acquaviva R. Anti-adipogenic and anti-oxidant effects of a standardised extract of Moro blood oranges (Citrus sinensis (L.) Osbeck) during adipocyte differentiation of 3T3-L1 preadipocytes. Nat Prod Res. 2021;35(16):2660-2667. doi: 10.1080/14786419.2019.1660337.PubMedUsed to support: Cell study: Morosil, added during the maturing of 3T3-L1 mouse fat-cell precursors, showed anti-adipogenic and antioxidant effects (less triglyceride build-up, lower expression of fat-making genes, lower reactive oxygen species). Laboratory work, not a human study.